Emily Rollins sold $85k of DLB
director at Dolby Laboratories, Inc.. 1,000 shares at an average of $84.90, traded Jan 30, 2025, filed Feb 3, 2025.
Score components
- +15RoleDirector
- +9Trade size$85k at market
- +5Share of holdings soldSold 13% of holdings
- +15Cluster3 insiders selling within 14 days
- -2010b5-1 planPre-scheduled under a 10b5-1 plan
What happened after comparable sells
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0000950170-25-012639, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Jan 30, 2025 | SOpen-market sale Class A Common Stock10b5-1 | -1,000 | $84.90 | $85k | 6,493 | Feb 3, 2025 |
Related signals
Other insiders at Dolby Laboratories, Inc. and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 0Weak | Dolby Laboratories, Inc. | John D Couling SVP, Entertainment | $451k 7,667 shares | -4% | |
| 0Weak | Dolby Laboratories, Inc. | John D Couling SVP, Entertainment | $468k 7,667 shares | -6% | |
| 20Weak | Dolby Laboratories, Inc. | Kevin J Yeaman President and CEO | $1.8M 25,000 shares | -18% | |
| 41Moderate | Dolby Laboratories, Inc. | Shriram Revankar SVP, Advanced Technology Group | $524k 7,000 shares | -9% | |
| 28Weak | Dolby Laboratories, Inc. | Kevin J Yeaman President and CEO | $1.8M 25,000 shares | -18% | |
| 25Weak | Dolby Laboratories, Inc. | Kevin J Yeaman President and CEO | $3.2M 42,366 shares | -27% | |
| 20Weak | Dolby Laboratories, Inc. | Kevin J Yeaman President and CEO | $1.9M 25,000 shares | -18% | |
| 28Weak | Dolby Laboratories, Inc. | Kevin J Yeaman President and CEO | $2.6M 33,683 shares | -23% | |
| 18Weak | Dolby Laboratories, Inc. | Mark Andrew Sherman EVP, Gen. Counsel & Secretary | $1.1M 15,000 shares | -19% | |
| 8Weak | Dolby Laboratories, Inc. | Mark Andrew Sherman EVP, Gen. Counsel & Secretary | $26k 350 shares | -1% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.